Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
基本信息
- 批准号:7895193
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-20 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnteriorBile fluidBlood ProteinsCardiacCell AdhesionCell Culture TechniquesCellsDataDefectDevelopmentDiseaseDoseDrug Metabolic DetoxicationEmbryoEmbryonic DevelopmentEndocrineEndodermEventExhibitsExocrine GlandsFibroblast Growth FactorGastrulaGene ExpressionGenerationsGeneticGenetic ProgrammingGlucoseGlycogenGoalsHepaticHepatocyteHindgutHumanIn VitroIntestinesKnock-outKnowledgeLateralLifeLigandsLinkLiverLiver diseasesMammalsMediatingMesodermMethodsModelingMolecularMorphogenesisMusOperating SystemOrganPathway interactionsPatternPhenotypePrimitive foregut structurePublishingReportingRepressionResearchRoleSignal TransductionSiteSomitesSourceStagingTestingTimeTissue TransplantationTissuesTranslatingUndifferentiatedXenopusbeta catenincell typeembryonic stem cellhuman diseasehuman embryonic stem cellinsightliver transplantationmonolayermutantprogenitorpublic health relevancereceptorresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this proposal is to elucidate the molecular mechanism controlling mammalian foregut and early liver development. The largest exocrine gland in the body the liver produces bile and is the primary site for detoxification. It also performs important endocrine functions by secreting homeostatic blood proteins and regulating glucose levels through glycogen storage. A recent trans-NIH report "Action Plan for Liver Disease Research (2004)" recognized that a better understanding of embryonic liver development would provide important insights into human liver disease and promote our ability to harness embryonic stem cells as a renewable source of tissue for transplantation. The mouse embryonic liver is induced from the ventral foregut endoderm by FGF signals from the cardiac mesoderm. While we increasingly understand the genetic pathways regulating proliferation and differentiation of hepatoblasts after the liver bud has formed, the earlier events linking endoderm patterning to hepatic specification are less clear. In Xenopus we recently determined that differential Wnt/beta-catenin signaling regulates endoderm fates. Our data supports a model where during gastrula and early somite stages secreted Wnt- antagonists in the anterior endoderm establish foregut identity and initiate a molecular cascade leading to liver development. In contrast, the posterior endoderm has high beta-catenin activity, due to Wnt ligands secreted from the lateral/axial mesoderm, which represses foregut fate and promotes intestinal development. We propose to test this hypothesis using mouse genetics and embryonic explants to characterize the underlying molecular mechanism. Moreover, we will investigate whether analogous pathways are important for liver development in humans using endoderm cultures derived from human embryonic stem cells. The results of this proposal will directly impact efforts to generate therapeutically useful endoderm tissue for the treatment of liver disease in humans. Aim 1. Determine if repression of beta-catenin activity in the anterior endoderm is required for foregut and liver development using mouse genetics. Aim 2. Define when beta-catenin needs to be repressed and examine how the temporally distinct Wnt and FGF pathways interact during hepatic development, using mouse embryonic explant cultures. Aim 3. Investigate the role of Wnt signaling in promoting human foregut and liver lineages from HESCs. PUBLIC HEALTH RELEVANCE. The liver is a vital organ providing many essential functions and numerous diseases are so life threatening that liver transplantation is the only option. The differentiation of liver cells from embryonic stem cells is a potentially renewable source of tissue for transplantation. The goal of this proposal is to elucidate the genetic programs controlling embryonic liver development in mice. We will then use this information to recapitulating the key embryonic events in human embryonic stem cells to more effectively generate liver tissue in culture.
描述(由申请人提供):该提案的长期目标是阐明控制哺乳动物前肠和早期肝发育的分子机制。人体中最大的外分泌腺会产生胆汁,是排毒的主要部位。它还通过分泌稳态血蛋白并通过糖原储存来调节葡萄糖水平来执行重要的内分泌功能。最近的Trans NIH报告“肝病研究行动计划(2004年)”认识到,对胚胎肝发育的更好理解将为人类肝病提供重要的见解,并促进我们利用胚胎干细胞作为可再生组织来源的能力,作为可再生的组织来源移植。小鼠胚胎肝脏是由心脏中胚层的FGF信号从腹侧前胚层诱导的。虽然我们越来越了解肝芽形成后调节肝细胞增殖和分化的遗传途径,但较早的事件将内胚层与肝规范联系起来尚不清楚。在爪蟾中,我们最近确定差异Wnt/beta-catenin信号传导调节内胚层命运。我们的数据支持了一个模型,在胃术和早期各阶段,内胚层中分泌的wnt拮抗剂建立了前体的身份,并启动分子级联反应,从而导致肝发育。相反,由于从外侧/轴向中胚层分泌的Wnt配体引起的后内胚层具有较高的β-catenin活性,后者抑制了前肢的命运并促进了肠道发育。我们建议使用小鼠遗传学和胚胎外植体检验这一假设,以表征潜在的分子机制。此外,我们将使用源自人类胚胎干细胞的内胚层培养物来研究类似途径对于人类肝发育是否重要。该提案的结果将直接影响产生治疗有用的内胚层组织的努力,以治疗人类的肝病。 AIM 1。确定使用小鼠遗传学的前肢和肝脏发育中需要抑制前内胚层中β-catenin活性的抑制。 AIM 2。定义何时需要抑制β-catenin,并检查使用小鼠胚胎源培养物在肝发育过程中时间上不同的Wnt和FGF途径如何相互作用。 AIM 3。研究Wnt信号在促进hESCS的人类前肢和肝谱系中的作用。公共卫生相关性。 肝脏是一个重要的器官,提供了许多基本功能,许多疾病威胁着生命,以至于肝移植是唯一的选择。肝细胞与胚胎干细胞的分化是可再生的组织来源。该提案的目的是阐明控制小鼠胚胎肝发育的遗传程序。然后,我们将使用这些信息来概括人类干细胞中的关键胚胎事件,以更有效地在培养中产生肝组织。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James M Wells其他文献
ヒトiPS細胞由来膵島オルガノイドのサイズ制御による効率的な分化誘導
通过控制人 iPS 细胞来源的胰岛类器官的大小进行有效分化诱导
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
浅見柚羽;草森浩輔;西川元也;James M Wells - 通讯作者:
James M Wells
Mechanism and in vitro reconstruction of mammalian trachea-esophageal development
哺乳动物气管食管发育机制及体外重建
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Lu Han;Praneet Chaturvedi;Keishi Kishimoto;Hiroyuki Koike;Talia Nasr;Kentaro Iwasawa;Kirsten Giesbrecht;Phillip C Witcher;Alexandra Eicher;Lauren Haines;Yarim Lee;John M Shannon;Mitsuru Morimoto;James M Wells;Takanori Takebe;Aaron M Zorn;Keishi Kishimoto - 通讯作者:
Keishi Kishimoto
James M Wells的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James M Wells', 18)}}的其他基金
Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
- 批准号:
10458162 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
Modeling esophageal/respiratory birth defects in human pluripotent stem cell (PSC)-derived fetal tissues
在人类多能干细胞 (PSC) 衍生的胎儿组织中模拟食管/呼吸系统出生缺陷
- 批准号:
10174986 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
- 批准号:
10647838 - 财政年份:2017
- 资助金额:
$ 10万 - 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
- 批准号:
8415736 - 财政年份:2012
- 资助金额:
$ 10万 - 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
- 批准号:
8516139 - 财政年份:2012
- 资助金额:
$ 10万 - 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
- 批准号:
8665593 - 财政年份:2012
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
胆汁液晶与胆囊结石
- 批准号:30424018
- 批准年份:2004
- 资助金额:4.0 万元
- 项目类别:专项基金项目
胆汁液晶在胆囊结石形成过程中的作用机理的研究
- 批准号:39960024
- 批准年份:1999
- 资助金额:9.0 万元
- 项目类别:地区科学基金项目
人体胆汁液晶理化特性的研究
- 批准号:39560026
- 批准年份:1995
- 资助金额:7.0 万元
- 项目类别:地区科学基金项目